Numerous investigations in cell-free systems have been performed on the kinetics of the interaction between nuclear acceptor sites and steroid-receptor complexes in various organs and with various hormones. Many of the studies concluded that there existed a small number of high affinity acceptor sites for steroid-receptor complexes. On the contrary, some investigators reported that the binding of the complexes was non-saturable process (Chamness et al., 1974 , Simons et al., 1976 .
In rat liver, saturable and high affinity acceptor sites for DEX-receptor complex have been described . Recent investigations, however, suggested the opposite conclusion that the rat liver cytosol contained a receptor-translocation inhibitor that caused a pseudo-saturation of nuclei within the physiological range of the steroid-receptor complexes Atger, 1975, Atger and Milgrom, 1978) . In the present study, to examine the role of the translocation inhibitor, biochemical characteristics of the inhibitor were further investigated. Analytical methods DNA and protein were determined by the methods of Burton (1956) and Lowry et al.(1951) using calf thymus DNA and bovine serum albumin as the standards, respectively.
The radioactivity was determined in a Tri-carb liquid scintillation spectrometer, model3380, with automatic standardization for quenching correction. in the following experiments. As indicated by others (Atger and Milgrom, 1978) , the inhibitor destroys neither the active receptor complex (not shown) nor the nuclear acceptor sites. Liver nuclei pre-incubated in the presence of3different concentrations of the inhibitor retained their native ability to bind3H-DEX-receptor complex (Fig.2) . For further characterisation of the possible mechanism of the inhibition, two models constructed by Simons et al.(1976) were examined.
At the fixed values of the total inhibitor and free, active receptorcomplex, varying the total acceptor concentration NT will produce a change in the ratio, bound receptor Ns/total acceptor NT, with one model, where the competition between the inhibitor and the complex for acceptor sites is expected. As shown in Fig.  3 , Ns/NT is constant over a5-fold increase in NT. This result is consistent with the other model where interaction of the inhibitor with the receptor-complex is expected to reduce the affinity of the complex for acceptor sites. In addition, the binding of various concentrations of3H-DEX-receptor complex prepared from the adult liver by nuclei from the fetal liver was examined, in the presence or absence of a fixed amount of the inhibitor, by the analysis of Scatchard plot (Fig.4) . As reported previously , saturable and high affinity acceptor sites for the3H-DEX-receptor complex were observed in nuclei from the fetal liver. The nuclear binding did not seem to be a and Milgrom, 1978) . Binding of cytoplasmic3H-steroid-receptor complexes from the liver, the thymus and the ventral prostate by nuclei from the liver, the kidney, the spleen, the thymus and the ventral prostate Since the inhibition specifity of the receptor translocation to nuclei by the hepatic inhibitor was expected, the bindings of3H-steroid-receptor complexes by nuclei in the presence or absence of the inhibitor were examined. The cytoplasmic 3H-DEX-receptor complexes from the liver and the thymus and the3H-DHT-receptor complex from the ventral prostate were taken up by nuclei derived not only from the homologous tissue but also from different tissue origins and the amounts of the receptor complexes bound by nuclei in a standard incubation condition were expressed as the bound radioactivity per mg DNA (Table3).
The binding of3H-DEX-receptor complex derived from the thymus cytosol by nuclei was the most efficient among those of steroid-receptor complexes examined. Since significant amounts of the complexes bound to the,micleii, the inhibition rates of of steroid-receptor complexes from the liver, the thymus and the prostate, respectively) in the presence or absence of partially purified inhibitor of the liver. Other experimental conditions appear in "materials and methods". the binding of the receptor complex by nuclei in the presence of a fixed concentration of the inhibitor were examined. Except the binding of DEX-receptor complexes by the kidney nuclei, the bindings of glucocorticoid-receptor complexes by the other nuclei were efficiently inhibited in the presence of the inhibitor. On the other hand, the efficient binding of3H-DHT-receptor complex by nuclei derived from the liver and the ventral prostate was observed as reported and was significantly inhibited in the presence of the inhibitor.
Among the bindings of steroidreceptor complexes by nuclei in the presence of the inhibitor, the highest rate of the inhibition of the binding was observed in a system consisting of hepatic3H-DEXreceptor complex and nuclei derived from the homologous tissue.
Effects of DEX-administration on the nuclear binding of3H-DEX-receptor complex Since the alteration of binding properties of nuclear acceptor sites for the receptor complex by the DEX-administration was expected, hepatic nuclei derived from the adrenalectomized and DEX-treated rats were incubated with the3H-DEX-receptor complex in the presence or absence of the inhibitor. However, no significant difference in the binding of the DEX-receptor complex by the nuclei and in the inhibition rates of the binding was noticed (Table  4) .
Discussion
The present results provide a further support to the conclusion by Atger and Milgrom (1978) , Beato el al., 1973 were found to be an artifact of pseudosaturability of nuclei due to the presence of a cytosol inhibitor. In addition, some biochemical characteristics of the cytoplasmic inhibitor in rat tissues were examined as a clue to evaluate whether the inhibitory material might play any physiological role or not in vivo. The inhibitor was noticed not only in the cytosol of the liver, but also in the cytosols of the spleen, the kidney and the thymus. The cytoplasmic inhibitor of the liver seems to be a macromolecule inactivated by a trypsin digestion. On the other hand, the inhibitor was eluted with the buffer containing 300mm KCl on DEAE-cellulose chromatography and was clearly separated from the DEX-receptor complex of the homologous tissue. The inhibition mechanism of the inhibitor seemed to be a direct interaction between the steroid-receptor complex and the inhibitor in a concentration-dependent way, as suggested by others (Simons et al., 1976, Atger and Milgrom, 1978) In addition, this inhibition seemed to be less specific for the bindings of different steroidreceptor complexes to nuclei, though the inhibition rate of the binding of hepatic 3H-DEX-receptor complex to nuclei from the homologous tissue was observed to be the highest among steroid-receptor complexes examined.
However, these results may be attributable, in part, to the difference in the susceptibility of steroidreceptor complexes to the inhibitor. When 3H -DEX-receptor complex from the liver or from the thymus was incubated with the kidney nuclei, the amount of the complex bound to the nuclei was the least among nuclei examined and the binding was not inhibited significantly in the presence of the inhibitor. This may suggest that the binding of3H-DEX-receptor complex by the kidney nuclei is dissimilar to those by three other nuclei. 
